HIV Infections: all 4,342 studies
Page 29 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male VolunteersCompletedNCT00648817Phase 4
- HIV Counseling and Testing and Linkage to Care in UgandaCompletedNCT00648232Not applicable
- Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected PatientsCompletedNCT00647244Phase 4
- Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOTCompletedNCT00647205Phase 4
- Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL TrialCompletedNCT00643968Phase 4
- Effectiveness of Coping Training for People With HIV Experiencing Treatment Side Effects (The Balance Project)CompletedNCT00643903Not applicable
- Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency VirusCompletedNCT00643643Phase 2
- HIV Prevention With the Mentally IllCompletedNCT00643305Phase 2
- Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and VomitingCompletedNCT00642499Phase 2
- An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric SubjectsCompletedNCT00642291Phase 2
- Impact of Antiretroviral Therapy on Cardiac BiomarkersCompletedNCT00641888
- Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South AfricaCompletedNCT00640887Phase 2
- Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by BreastfeedingCompletedNCT00640263Phase 3
- Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in UgandaCompletedNCT00639938Phase 3
- Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site ProtocolCompletedNCT00639145
- Reactogenicity and Immunogenicity of Vaginal CNgp140TerminatedNCT00637962Phase 1
- Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241)CompletedNCT00632073Phase 1
- Experimental Design of Couple Counseling and Testing in Antenatal Clinics in Dar es Salaam, TanzaniaCompletedNCT00631384Not applicable
- Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based RegimensCompletedNCT00627055Phase 4
- Lopinavir/Ritonavir Monotherapy in ChildrenCompletedNCT00626301Phase 4
- Early Versus Delayed Routine HIV Testing in Connecticut JailsCompletedNCT00624247Early Phase 1
- Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy AdultsTerminatedNCT00623753Phase 1
- Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected SubjectsCompletedNCT00623259Phase 1
- Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)CompletedNCT00623051Not applicable
- A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 TrialStatus unknownNCT00622232Phase 2
- Pharmacokinetics of Low Dose RitonavirCompletedNCT00622206Phase 1/2
- Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir®WithdrawnNCT00622141Phase 1/2
- Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant WomenCompletedNCT00621166Phase 2
- Drug Interaction Study Between Lumefantrine and Lopinavir/RitonavirCompletedNCT00619944Phase 4
- Cognitive Stimulation Program in AIDSCompletedNCT00619567Phase 1
- Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy AdultsCompletedNCT00618605Phase 1
- Pharmacokinetic Study on Raltegravir and LamotrigineCompletedNCT00618241Phase 1
- Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation CohortCompletedNCT00618176Phase 4
- Naïve HIV POC Monotherapy TrialCompletedNCT00617526Phase 2
- ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation TrialCompletedNCT00615810Phase 4
- ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to AtriplaCompletedNCT00615745Phase 4
- Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)CompletedNCT00615563
- INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.CompletedNCT00615134Phase 2
- Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced PopulationCompletedNCT00614302
- A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal GelsCompletedNCT00613249Phase 1
- Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV InfectionTerminatedNCT00612898Phase 2/3
- Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification StrategyCompletedNCT00611039Phase 4
- Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 HoursCompletedNCT00607958Phase 4
- Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During PregnancyCompletedNCT00605098Phase 4
- Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIVCompletedNCT00602758Not applicable
- Bioequivalency Study of Zidovudine Under Fasting ConditionsCompletedNCT00602550Not applicable
- Bioequivalency Study of Zidovudine Under Fed ConditionsCompletedNCT00601562Not applicable
- Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk PreventionCompletedNCT00601237Not applicable
- Mindfulness Meditation Training in HIVCompletedNCT00600561Phase 2
- Pharmacotherapy for HIV+ Stimulant Dependent IndividualsStatus unknownNCT00599573Not applicable
- Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials (the ACT2 Project)CompletedNCT00593983Phase 2
- Relationship Between HIV-1 Subtype and ARV ResponseCompletedNCT00585793
- CNS (Central Nervous System) Viral Dynamics and Cellular Immunity During AIDSCompletedNCT00583167
- Family Access to Care Study (FACS)CompletedNCT00582218
- Family-Based HIV Prevention for LatinosCompletedNCT00582101Phase 1
- Role of Positive Affect in Adjustment to HIVCompletedNCT00582023
- HIV Resistance and Treatment StrategiesCompletedNCT00581802
- Evaluation of Enrollment, Dynamics of Care and Patient Outcomes in the NYS Medicaid HIV Special Needs PlansCompletedNCT00577811
- Understanding the Increased Risk of Cardiovascular Disease in People With HIVCompletedNCT00577681
- Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative AdultsCompletedNCT00574600Phase 1
- Energy Specific Far Infrared Radiation Treatment for AIDSStatus unknownNCT00574522Phase 1
- Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)CompletedNCT00573001Phase 3
- Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric PopulationCompletedNCT00567749
- CDC HIV Testing Guidelines: Unresolved Ethical ConcernsCompletedNCT00564369Not applicable
- Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus LercanidipineStatus unknownNCT00564057Phase 4
- Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected AdultsCompletedNCT00562939Phase 1/2
- Nutrition Intervention in Drug Naive HIV-infected Kenyan Women and Their ChildrenCompletedNCT00562874Not applicable
- Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 RecoveryTerminatedNCT00562510Phase 3
- Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir GelCompletedNCT00561496Phase 1
- Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV TherapyTerminatedNCT00559416Phase 1
- Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral SuppressionCompletedNCT00554398Phase 3
- Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected PatientsCompletedNCT00551655
- Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)CompletedNCT00551330Phase 2
- Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875)CompletedNCT00551018Phase 2
- A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African AdultsCompletedNCT00549523Phase 1/2
- The Role of Diet Education and Nutritional Counselling in the Ongoing Care of People Living With HIV in ThailandCompletedNCT00549367Not applicable
- Study of a Potential Preventive Vaccine Against HIV in Healthy VolunteersCompletedNCT00545987Phase 1
- Pediatric Expanded Access Program-Oral Solution (0831-908)CompletedNCT00543530Phase 3
- A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)CompletedNCT00541463Phase 2
- Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean DeliveryCompletedNCT00540605Phase 1
- The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive SubjectsCompletedNCT00540137Phase 4
- Improving Provider Counseling Interventions in HIV PracticeCompletedNCT00538993Not applicable
- A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)Status unknownNCT00532974Phase 1
- Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/MclCompletedNCT00532168Phase 4
- HIV - Monotherapy in Switzerland (MOST-ch)TerminatedNCT00531986Phase 4
- Double Protease Inhibitor to Darunavir Switch StudyCompletedNCT00531557Phase 4
- TMC 125 Blood Levels StudyCompletedNCT00531323Phase 1
- A Randomized Controlled Trial of a Mindfulness-Based Stress Reduction Intervention for Men Living With HIVCompletedNCT00529971Phase 3
- Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat ProteinCompletedNCT00529698Phase 1
- Switching From PI to RALtegravir in HIV Stable PatientsCompletedNCT00528892Phase 3
- Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy AdultsCompletedNCT00528489Phase 1
- Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and TruvadaCompletedNCT00528060Phase 2
- HIV Antiretroviral Drugs and MetabolismStatus unknownNCT00525239Not applicable
- Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in TanzaniaCompletedNCT00523510Not applicable
- Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)CompletedNCT00523211Phase 3
- Integrase Inhibitor (MK-0518) Viral DecayCompletedNCT00520897Phase 2
- DDI HV (ATV - Merck)CompletedNCT00518297Phase 1
- Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected PatientsStatus unknownNCT00517569Phase 1
- Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV InfectionCompletedNCT00514605Phase 2/3
- Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide TrialsCompletedNCT00514098